Adriano Arguedas
Research Subjects
Adriano Arguedas has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Carolina Soley
Instituto de Atención Pediátrica, San José, Costa Rica
9 shared publicationsRon Dagan
5 shared publicationsNurith Porat
Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
4 shared publicationsCecilia Loaiza
3 shared publicationsSilvia Guevara
Instituto de Atención Pediátrica, San José, Costa Rica
3 shared publicationsAlexandra Pérez
2 shared publications
Latest Publications
- 28 July 2015
- Published by IOS Press in Journal of Pediatric Infectious Diseases
- Vol. 05 (01) , 065-069
Etiological and demographic characteristics between unilateral and bilateral otitis media in Costa Rican children
Data from Latin America describing the potential differences among children with unilateral or bilateral otitis media are scarce and needed in order to implement appropriate prevention actions and specific antimicrobial recommendations. The present study analyzed the demographic and microbiologic characteristics of 1,427 Costa Rican children with unilateral and bilateral otitis media in whom a tympanocentesis was performed between 1992 and 2006 (median age: 23 months; range two to 150 months). There were no significant differences in the demographics, microbiology and antimicrobial susceptibility among middle ear fluid isolates obtained from both populations. The only significant finding was observed in children with Moraxella catarrhalis otitis media that was observed more frequently than other bacterial pathogen in the middle ear fluid of children with unilateral acute otitis media that were < 24 months of age and during the rainy season.
- 28 July 2015
- Published by IOS Press in Journal of Pediatric Infectious Diseases
- Vol. 05 (01) , 065-069
Etiological and demographic characteristics between unilateral and bilateral otitis media in Costa Rican children
Data from Latin America describing the potential differences among children with unilateral or bilateral otitis media are scarce and needed in order to implement appropriate prevention actions and specific antimicrobial recommendations. The present study analyzed the demographic and microbiologic characteristics of 1,427 Costa Rican children with unilateral and bilateral otitis media in whom a tympanocentesis was performed between 1992 and 2006 (median age: 23 months; range two to 150 months). There were no significant differences in the demographics, microbiology and antimicrobial susceptibility among middle ear fluid isolates obtained from both populations. The only significant finding was observed in children with Moraxella catarrhalis otitis media that was observed more frequently than other bacterial pathogen in the middle ear fluid of children with unilateral acute otitis media that were < 24 months of age and during the rainy season.
- 28 July 2015
- Published by IOS Press in Journal of Pediatric Infectious Diseases
- Vol. 06 (04) , 243-246
Streptococcus pneumoniae serotype 6C in Costa Rican children with otitis media before introduction of the 7-valent pneumococcal conjugated vaccine into the national immunization program
During the years 1999 through 2008 middle ear fluid (MEF) and nasopharyngeal/oropharyngeal (NP/OP) samples were obtained from Costa Rican children with otitis media (OM). Streptococcus pneumoniae was identified and serotyped according to standard procedures. A total of 1,389 MEF isolates were collected, of which 353 (25%) were S. pneumoniae. Serotyping was performed in 286/353 (81%) isolates, of which 40 (14%) were serogroup 6: serotype 6A (10/40; 25%), 6B (27/40; 67%) and 6C (3/40; 8%). Among 755 NP/OP S. pneumoniae isolated, 537 (71%) were serotyped and serogroup 6 was identified in 112 (21%) isolates: 6A (24/112; 21%), 6B (78/112; 70%), and 6C (10/112; 9%). Twenty percent, 86% and 0% of serotypes 6A, 6B and 6C isolated from the MEF, respectively, were penicillin non-susceptible (MIC ≥ 0.06 μg/mL) and among the NP/OP isolates, 25%, 17.9% and 10%, respectively, were penicillin non-susceptible. Our results show that in Costa Rican children with OM, S. pneumoniae serotype 6C is an infrequent cause of OM and is sporadically found in NP/OP samples.
- 28 July 2015
- Published by IOS Press in Journal of Pediatric Infectious Diseases
- Vol. 06 (04) , 243-246
Streptococcus pneumoniae serotype 6C in Costa Rican children with otitis media before introduction of the 7-valent pneumococcal conjugated vaccine into the national immunization program
During the years 1999 through 2008 middle ear fluid (MEF) and nasopharyngeal/oropharyngeal (NP/OP) samples were obtained from Costa Rican children with otitis media (OM). Streptococcus pneumoniae was identified and serotyped according to standard procedures. A total of 1,389 MEF isolates were collected, of which 353 (25%) were S. pneumoniae. Serotyping was performed in 286/353 (81%) isolates, of which 40 (14%) were serogroup 6: serotype 6A (10/40; 25%), 6B (27/40; 67%) and 6C (3/40; 8%). Among 755 NP/OP S. pneumoniae isolated, 537 (71%) were serotyped and serogroup 6 was identified in 112 (21%) isolates: 6A (24/112; 21%), 6B (78/112; 70%), and 6C (10/112; 9%). Twenty percent, 86% and 0% of serotypes 6A, 6B and 6C isolated from the MEF, respectively, were penicillin non-susceptible (MIC ≥ 0.06 μg/mL) and among the NP/OP isolates, 25%, 17.9% and 10%, respectively, were penicillin non-susceptible. Our results show that in Costa Rican children with OM, S. pneumoniae serotype 6C is an infrequent cause of OM and is sporadically found in NP/OP samples.
- 1 November 2011
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (11) , 5022-5026
Comparison of Azithromycin Pharmacokinetics following Single Oral Doses of Extended-Release and Immediate-Release Formulations in Children with Acute Otitis Media
An azithromycin extended-release (ER) oral suspension was developed to improve the gastrointestinal tolerability profile without substantially compromising systemic exposure. A single dose of 30 mg/kg azithromycin immediate-release (IR) oral suspension has been used in children to treat acute otitis media (AOM). This study was conducted to compare the pharmacokinetics of a 60-mg/kg azithromycin ER single dose with a 30-mg/kg azithromycin IR single dose in children with AOM aged 6 months to 6 years (n = 19 per treatment). Serum samples were collected at 1, 2, 3, 4, 8, 24, 48, and 72 h after dosing. The area under the curve from time zero to 72 h postdosing (AUC0-72) was calculated based on a noncompartmental method. One-way analysis of variance (ANOVA) was used to compare exposure parameters (e.g., AUC0-72 and peak concentration) as well as concentrations at each time point. The adjusted geometric mean ratio of the ER/IR AUC0-72 was 157.98% (90% confidence interval [CI], 98.87%, 252.44%), which met the predefined criterion of the lower boundary of the 90% CI of ≥80%. As expected, due to the slower-release profile of the ER formulation, the concentrations of the ER formulation during the first 3 h were lower than those of the IR formulation. After 3 h postdosing, the lower boundaries of the 90% CI for the ER/IR concentration ratios were greater than 100%. These results indicated that a 60-mg/kg single dose of ER azithromycin provides similar or greater systemic exposure in children than the 30-mg/kg single dose of IR azithromycin.
- 1 November 2011
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (11) , 5022-5026
Comparison of Azithromycin Pharmacokinetics following Single Oral Doses of Extended-Release and Immediate-Release Formulations in Children with Acute Otitis Media
An azithromycin extended-release (ER) oral suspension was developed to improve the gastrointestinal tolerability profile without substantially compromising systemic exposure. A single dose of 30 mg/kg azithromycin immediate-release (IR) oral suspension has been used in children to treat acute otitis media (AOM). This study was conducted to compare the pharmacokinetics of a 60-mg/kg azithromycin ER single dose with a 30-mg/kg azithromycin IR single dose in children with AOM aged 6 months to 6 years (n = 19 per treatment). Serum samples were collected at 1, 2, 3, 4, 8, 24, 48, and 72 h after dosing. The area under the curve from time zero to 72 h postdosing (AUC0-72) was calculated based on a noncompartmental method. One-way analysis of variance (ANOVA) was used to compare exposure parameters (e.g., AUC0-72 and peak concentration) as well as concentrations at each time point. The adjusted geometric mean ratio of the ER/IR AUC0-72 was 157.98% (90% confidence interval [CI], 98.87%, 252.44%), which met the predefined criterion of the lower boundary of the 90% CI of ≥80%. As expected, due to the slower-release profile of the ER formulation, the concentrations of the ER formulation during the first 3 h were lower than those of the IR formulation. After 3 h postdosing, the lower boundaries of the 90% CI for the ER/IR concentration ratios were greater than 100%. These results indicated that a 60-mg/kg single dose of ER azithromycin provides similar or greater systemic exposure in children than the 30-mg/kg single dose of IR azithromycin.
- 27 January 2011
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 15 (4) , e240-e248
Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media
- 27 January 2011
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 15 (4) , e240-e248
Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media
- 31 December 2010
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 74 (12) , 1419-1424
Otitis media across nine countries: Disease burden and management
- 31 December 2010
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 74 (12) , 1419-1424
Otitis media across nine countries: Disease burden and management
- 1 February 2009
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 33 (2) , 163-167
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection
- 1 February 2009
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 33 (2) , 163-167
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection